Cytokinetics (CYTK) Misses Q3 EPS by 35c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $67.59 +0.04%
Revenue Growth %: +1,966.3%
Financial Fact:
License revenues from related parties: 53.03M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +1,966.3%
Financial Fact:
License revenues from related parties: 53.03M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($1.52), $0.35 worse than the analyst estimate of ($1.17). Revenue for the quarter came in at $2.52 million versus the consensus estimate of $3.16 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- UBS Downgrades NAVER Corp. (035420:KS) (NHNCF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
